(1S,3aR,6aS)-Octahydrocyclopenta[c]pyrrole-1-carboxylic acid hydrochloride, 95.0%, 250mg

ethyl 5-amino-1-(4-chlorophenyl)-1H-pyrazole-3-carboxylate, 95.0%, 2g

4-Bromo-5,6,7,8-tetrahydronaphthalen-1-amine hydrochloride, 97%, 5g

(S)-tert-Butyl 4-(tert-butyl)-1,2,3-oxathiazolidine-3-carboxylate 2,2-dioxide, 98%, 100mg

9,10-Diethynylanthracene, 98%, 250mg

4-Fluoro-2-methoxy-5-nitroaniline, 98.00%, 100g

3-Mercaptopropyltriethoxysilane, 97%, 25g

GC capillary column ROTI®Cap-1701 MS, 60 m, 0.32 mm, 0.25 µm, 1 Piece(s)

Bisindolylmaleimide I>97.0%(HPLC)5mg

4-Chlorophenylhydrazine hydrochloride, 93.0%, 100g

4-[4-Chloro-3-(trifluoromethyl)phenyl]-4-hydroxypiperidine>98.0%(GC)(T)5g

2-Amino-5-bromo-3-fluorobenzoic acid, 95.0%, 25g

Round bottom flask with standard ground joint 100 ml NS 19/26